Stay updated with breaking news from Boxed Warning. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Autoinjector recognized by the Arthritis Foundation with Ease of Use Certification Individualized patient support program “HADLIMA For You” available including co-pay support Designed to improve access and affordability for patients and the US health care system
The FDA has approved Litfulo (ritlecitinib) for the treatment of severe alopecia areata in adults and adolescents 12 years and older.
(RTTNews) - Gilead Sciences Inc. (GILD) said that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA)...
23.06.2023 - Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion for Trodelvy (sacituzumab govitecan) as monotherapy for the ...
The FDA has approved Columvi®® (glofitamab-gxbm) for the treatment of adult patients with R/R DLBCL after ≥2 or greater lines of systemic therapy.